NCT06049602招募中不适用
Efficacy of TDF and Entekavir Prophylaxis at Hepatitis B Reactivation: Multi Center Retrospective Study
Viral Hepatitis Society1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2023年1月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- Reactivation Rate
研究概览
简要总结
This is a non-interventional retrospective multi-center study for the patients received Entekavir or TDF for Hepatitis B prophylaxis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients used entekavir or TDF for Hepatitis B prophylaxis
排除标准
- •Patients lower then 18 years old.
结局指标
主要结局
Reactivation Rate
时间窗: 12 months
Percentage of patients reactivated during the Entekavir or TDF
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
4 期
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionChronic Hepatitis BNCT01594905Yonsei University90
已完成
1 期
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy VolunteerHCVHepatitis CHIVAIDSNCT00828789Tibotec BVBA20
Unknown
4 期
Antiviral Efficacy of Switching to ETV Plus TDFChronic Hepatitis BNCT01597934Yonsei University104
已完成
3 期
Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous TreatmentChronic Hepatitis BNCT01063036Bristol-Myers Squibb144
已完成
2 期
A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic HepatitisHepatitis B, ChronicNCT02499562Shanghai Genomics, Inc.168